Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
James L. Pacek | M | 74 | 18 años | |
Jeryl Hilleman | F | 67 | 5 años | |
Ross Beam | M | - | 21 años | |
Mika Nishimura | F | 60 | 3 años | |
Anshul Maheshwari | M | 44 | 3 años | |
Helen Loh | F | 60 | 3 años | |
Robyn Capobianco | M | - | 3 años | |
Scott A. Yerby | M | 56 | 3 años | |
Scott Schaffner | M | 54 | 14 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Hira V. Thapliyal | M | - | 5 años | |
Mark A. Reiley | M | 74 | 11 años | |
K. Newton | M | 61 | 5 años | |
David F. Fitzgerald | M | 90 | 11 años | |
Peter L. Wilson | M | 79 |
Keravision, Inc.
Keravision, Inc. Medical SpecialtiesHealth Technology Keravision, Inc. was developed medical products for the treatment of common vision problems. The company was developed a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia, hyperopia and astigmatism, to offer an alternative to eyeglasses, contact lenses and other vision correction surgical procedures. Its first product, Intacs corneal ring segments, based on its proprietary patented technology, has been approved by the FDA for correcting mild myopia. Intacs are the first surgical vision correction technology to be approved by the FDA for distribution and sales that is designed to permanently correct a patient's vision while providing the option of removability. Intacs are composed of two thin half-circles of polymer material that are inserted into the periphery of the cornea to reshape the curvature of the cornea to correct vision. | 15 años |
Michael A. Baker | M | 65 | 12 años | |
Terrence E. Geremski | M | 76 | 8 años | |
Robin Freestone | M | 65 | 7 años | |
Vinita Kundanlal Bali | F | 67 | 6 años | |
Gregory Belinfanti | M | 49 | 5 años | |
Mark Foley | M | 58 | 2 años | |
Richard W. Rew | M | 56 | 8 años | |
Tim Petersen | M | 60 | 3 años | |
James G. Foster | M | 77 | 12 años | |
David Bonita | M | 48 | 5 años | |
Erik Engstrom | M | 60 | 8 años | |
Christian P. Ahrens | M | 48 | 5 años | |
Barbara D. Boyan | M | 75 | 10 años | |
Tord Bertil Lendau | M | 67 | - | |
Richard A. Christensen | M | 64 | 8 años | |
Debby Holmes-Higgin | F | - | 8 años | |
Brian Szymczak | M | 51 | 8 años | |
John Molesphini | M | 66 | 7 años | |
Bret Schwartzhoff | M | 52 | 3 años | |
Leon Gregory Hoare | M | - | 1 años | |
Matthew Stober | M | 57 | - | |
Robert P. Wood | M | 65 |
Keravision, Inc.
Keravision, Inc. Medical SpecialtiesHealth Technology Keravision, Inc. was developed medical products for the treatment of common vision problems. The company was developed a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia, hyperopia and astigmatism, to offer an alternative to eyeglasses, contact lenses and other vision correction surgical procedures. Its first product, Intacs corneal ring segments, based on its proprietary patented technology, has been approved by the FDA for correcting mild myopia. Intacs are the first surgical vision correction technology to be approved by the FDA for distribution and sales that is designed to permanently correct a patient's vision while providing the option of removability. Intacs are composed of two thin half-circles of polymer material that are inserted into the periphery of the cornea to reshape the curvature of the cornea to correct vision. | - |
Norman R. Sanders | M | - | - | |
Fernando V. Sanchez | M | 70 | 4 años | |
Maria Lacerca-Allen | M | 57 | 1 años | |
David B. Applegate | M | - | 7 años | |
Rich Spano | M | - |
Keravision, Inc.
Keravision, Inc. Medical SpecialtiesHealth Technology Keravision, Inc. was developed medical products for the treatment of common vision problems. The company was developed a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia, hyperopia and astigmatism, to offer an alternative to eyeglasses, contact lenses and other vision correction surgical procedures. Its first product, Intacs corneal ring segments, based on its proprietary patented technology, has been approved by the FDA for correcting mild myopia. Intacs are the first surgical vision correction technology to be approved by the FDA for distribution and sales that is designed to permanently correct a patient's vision while providing the option of removability. Intacs are composed of two thin half-circles of polymer material that are inserted into the periphery of the cornea to reshape the curvature of the cornea to correct vision. | 2 años |
Heyward R. Donigan | F | 63 | - | |
Jean A. Woloszko | M | 66 | 16 años | |
Michael Gluk | M | 65 | 4 años | |
Fred Dinger | M | - | - | |
David Hovda | M | 62 | 7 años | |
John H. Giroux | M | 79 | 8 años | |
Richard Batt | M | 55 | 4 años | |
Sten Ivar Gunnar Dahlborg | M | 61 | 13 años | |
Gayle Wiley | F | 58 | 2 años | |
Gwen Chapman | F | - | 3 años | |
Art Pappas | M | 76 |
Keravision, Inc.
Keravision, Inc. Medical SpecialtiesHealth Technology Keravision, Inc. was developed medical products for the treatment of common vision problems. The company was developed a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia, hyperopia and astigmatism, to offer an alternative to eyeglasses, contact lenses and other vision correction surgical procedures. Its first product, Intacs corneal ring segments, based on its proprietary patented technology, has been approved by the FDA for correcting mild myopia. Intacs are the first surgical vision correction technology to be approved by the FDA for distribution and sales that is designed to permanently correct a patient's vision while providing the option of removability. Intacs are composed of two thin half-circles of polymer material that are inserted into the periphery of the cornea to reshape the curvature of the cornea to correct vision. | - |
Andrew Miclot | M | 69 | 4 años | |
John Thomas Raffle | M | 55 | 11 años | |
David F. Heniges | M | 80 |
Keravision, Inc.
Keravision, Inc. Medical SpecialtiesHealth Technology Keravision, Inc. was developed medical products for the treatment of common vision problems. The company was developed a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia, hyperopia and astigmatism, to offer an alternative to eyeglasses, contact lenses and other vision correction surgical procedures. Its first product, Intacs corneal ring segments, based on its proprietary patented technology, has been approved by the FDA for correcting mild myopia. Intacs are the first surgical vision correction technology to be approved by the FDA for distribution and sales that is designed to permanently correct a patient's vision while providing the option of removability. Intacs are composed of two thin half-circles of polymer material that are inserted into the periphery of the cornea to reshape the curvature of the cornea to correct vision. | 3 años |
Olivier Wolber | M | - | 1 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 50 | 89.29% |
Reino Unido | 6 | 10.71% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Bruce C. Prothro
- Red Personal